KR100493934B1 - The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one - Google Patents
The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one Download PDFInfo
- Publication number
- KR100493934B1 KR100493934B1 KR10-2002-0068236A KR20020068236A KR100493934B1 KR 100493934 B1 KR100493934 B1 KR 100493934B1 KR 20020068236 A KR20020068236 A KR 20020068236A KR 100493934 B1 KR100493934 B1 KR 100493934B1
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- salt
- isothiazolin
- hours
- sulfyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
Abstract
본 발명은 2-메틸-4-이소티아졸린-3-온 염의 제조방법에 관한 것으로서, 더욱 상세하게는 염소화제인 설프릴할라이드를 유기할로겐용매에 1.5 내지 2.5배의 비율로 희석한 다음, 이를 N,N'-디메틸-3,3'-디티오디프로피온아미드 용액에다 20 ~ 30℃의 온도에서 10 ~ 14 시간 동안 적가하므로서, 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 생성을 획기적으로 억제시킬 수 있는 신규한 제조방법에 관한 것이다.The present invention relates to a method for preparing 2-methyl-4-isothiazolin-3-one salt, and more particularly, to dilute sulfyl halide, a chlorinating agent, in an organic halogen solvent at a ratio of 1.5 to 2.5 times, and then To the N, N'-dimethyl-3,3'-dithiodipropionamide solution was added dropwise at a temperature of 20 to 30 ° C. for 10 to 14 hours, by-product 5-chloro-2-methyl-4-isothiazoline-3 It relates to a novel production method that can significantly suppress the production of-warm salt.
Description
본 발명은 2-메틸-4-이소티아졸린-3-온 염의 제조 방법에 관한 것으로서, 더욱 상세하게는 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 생성을 최대한 억제하고 고순도의 2-메틸-4-이소티아졸린-3-온 염을 제조할 수 있는 신규한 방법에 관한 것이다. The present invention relates to a method for preparing a 2-methyl-4-isothiazolin-3-one salt, and more particularly, to the production of a by-product 5-chloro-2-methyl-4-isothiazolin-3-one salt. A novel process for inhibiting and producing high purity 2-methyl-4-isothiazolin-3-one salts is provided.
다음 화학식(1)로 표시되는 2-메틸-4-이소티아졸린-3-온은 공업용 방부제나살균제로 널리 사용되고 있는 공지의 화합물이다.2-Methyl-4-isothiazolin-3-one represented by the following general formula (1) is a known compound widely used as an industrial preservative or bactericide.
화학식(1) 화학식(2) Formula (1) Formula (2)
일반적으로 상기 2-메틸-4-이소티아졸린-3-온은 먼저 2-메틸-4-이소티아졸린 -3-온 염을 제조한 다음, 이를 알카리염으로 중화시켜 염화수소를 제거하므로서 제조된다. 종래에도 2-메틸-4-이소티아졸린-3-온 염의 제조방법은 여러 가지가 알려져 있다. 그러나 종래 기술들의 문제점은 2-메틸-4-이소티아졸린-3-온 염을 제조할 때, 변이원성을 일으키는 독성이 있는 것으로 알려진 상기 화학식(2)의 5-클로로-2-메틸-4-이소티아졸린-3-온 염이 불가피하게 부산물로 생성된다는 사실이다. 그래서 종래 기술들의 공통적인 과제는 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 생성을 최대한 억제하고 고순도의 2-메틸-4-이소티아졸린-3-온 만을 제조하는 방법을 개발하는 것이었다. In general, the 2-methyl-4-isothiazolin-3-one is prepared by first preparing a 2-methyl-4-isothiazolin-3-one salt and then neutralizing it with an alkali salt to remove hydrogen chloride. Conventionally, various methods for producing 2-methyl-4-isothiazolin-3-one salt are known. However, a problem of the prior arts is that 5-chloro-2-methyl-4-iso of formula (2), which is known to be toxic for mutagenicity when preparing 2-methyl-4-isothiazolin-3-one salts It is a fact that thiazolin-3-one salts are inevitably produced as by-products. Therefore, a common problem of the prior arts is to suppress the production of 5-chloro-2-methyl-4-isothiazolin-3-one salt as a by-product as much as possible and to prepare only 2-methyl-4-isothiazolin-3-one of high purity. Was to develop a way.
종래에 알려진 2-메틸-4-이소티아졸린-3-온 또는 그 염의 제조방법을 살펴보면, 먼저 유럽 특허공고 제0095907호에는 N,N'-디메틸-3,3'-디티오디프로피온아미드를 염소 기체와 반응시켜 클로로화 및 고리화 반응을 진행시키는 방법이 소개되어 있다. 그러나, 이러한 방법에서는 목적화합물인 2-메틸-4-이소티아졸린-3-온 염과 함께 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염이 다량 생성되는 바, 이 중 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염은 전술한 바와 같이 독성이 높아서 인체에의 적용이 곤란하고, 상온에서의 안정성이 떨어지게 되므로 수주일 이상 사용할 경우, 그 유효성이 소실되는 문제점이 있었다. Looking at the known method for preparing 2-methyl-4-isothiazolin-3-one or its salts, European Patent Publication No. 0095907 discloses N, N'-dimethyl-3,3'-dithiodipropionamide as chlorine. A method of reacting with a gas to proceed with chlorolation and cyclization reactions is introduced. However, this method produces a large amount of by-product 5-chloro-2-methyl-4-isothiazolin-3-one salt together with the target compound 2-methyl-4-isothiazolin-3-one salt. Among these, 5-chloro-2-methyl-4-isothiazolin-3-one salt, which is a by-product, is highly toxic as described above, which makes it difficult to apply to the human body and reduces stability at room temperature. However, there was a problem that the validity is lost.
또한, 대한민국 특허출원 제91-7541호에서는 유기할로겐용매 중에서 N,N'-디메틸-3,3'-디티오디프로피온아미드에다 염소화제로 설프릴할라이드를 첨가하여 -20 ~ 10℃의 온도에서 반응시키는 기술이 개시되어 있다. 이 특허기술에 따르면 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 함량을 대폭 줄 일수 있기는 하지만 여전히 상당량의 5-클로로-2-메틸-4-이소티아졸린-3-온 염을 포함하고 있어서 이를 산업적으로 이용할 수 있는 수준에 이르지는 못하고 있었다.In addition, Korean Patent Application No. 91-7541 discloses N, N'-dimethyl-3,3'-dithiodipropionamide in an organic halogen solvent and sulfyl halide as a chlorinating agent to react at a temperature of -20 to 10 ° C. Techniques are disclosed. According to the patented technology, it is possible to drastically reduce the content of 5-chloro-2-methyl-4-isothiazolin-3-one salts, but still a considerable amount of 5-chloro-2-methyl-4-isothiazoline-3- Because it contains warm salt, it has not reached the level of industrial use.
대한민국 특허출원 제2001-62688에는 염화수소가 불용성 또는 난용성인 용매중에서 염소가스를 염소화제로 사용하여 고순도의 2-메틸-4-이소티아졸린-3-온 염을 얻은 후, 이 염을 무기염기나 유기 아민류로 중화한 후 추출하여 2-메틸-4-이소티아졸린-3-온을 얻는 방법을 소개하고 있다. 이 방법 역시, 비교적 고순도이기는 하지만 그래도 0.1%에서 많게는 1.0%까지의 5-클로로-2-메틸-4-이소티아졸린-3-온을 포함하고 있으며, 특히 반응 공정이 염소가스를 사용하는 기체반응이기 때문에 공업적으로 작업이 용이치 않은 단점이 있었다. Korean Patent Application No. 2001-62688 discloses a high-purity 2-methyl-4-isothiazolin-3-one salt using chlorine gas as a chlorinating agent in a solvent in which hydrogen chloride is insoluble or poorly soluble, and then the salt is used as an inorganic base or an organic solvent. The method of neutralizing with amines and then extracting to obtain 2-methyl-4-isothiazolin-3-one is introduced. This method also contains 5-chloro-2-methyl-4-isothiazolin-3-one, which is relatively high purity but still ranges from 0.1% to as high as 1.0%, especially where the reaction process uses gaseous chlorine gas. Because of this, there was a disadvantage that the operation is not easy industrially.
한편, 본 출원인은 대한민국 특허출원 제2002-54204호에서 다음 화학식(3)으로 표시되는 N-할로겐석신이미드를 염소화제로 사용하는 기술을 소개한 바 있다.On the other hand, the present applicant has introduced a technique using N-halogensuccinimide represented by the following formula (3) as a chlorinating agent in the Republic of Korea Patent Application 2002-54204.
화학식(6) Formula (6)
(상기 식에서, X는 Cl 또는 Br을 나타낸다.)(Wherein X represents Cl or Br).
상기 기술에서는 고체 원료인 N-할로겐석신이미드를 연소화제로 사용함으로써, 작업성이 뛰어나고, 제조 공정에서 인체에 유해한 가스가 발생하는 것을 방지할 수 있으면서도 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 발생을 획기적으로 줄일 수 있는 장점이 있으나, 염소화제인 N-할로겐석신이미드가 다소 고가이기 때문에 경제적인 측면에서는 여전히 개선의 여지가 남아 있었다. In the above technique, by using N-halogensuccinimide, which is a solid raw material, as a combustor, it is excellent in workability, and it is possible to prevent the generation of harmful gases to the human body in the manufacturing process, but it is 5-chloro-2-methyl-4 as a by-product. -There is a merit that can drastically reduce the occurrence of isothiazolin-3-one salt, but there is still room for improvement in terms of economics because N-halogensuccinimide, a chlorinating agent, is rather expensive.
이에 본 발명자들은 상기와 같은 종래 기술들의 문제점을 개선시키기 위하여 연구 노력하던 중, N,N'-디메틸-3,3'-디티오디프로피온아미드와 설프릴할라이드를 반응시킬 때 설프릴할라이드를 유기할로겐용매에 희석하여 적가 반응시키되, 설프릴할라이드의 희석 비율 및 적가 속도에 따라 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 생성비율이 크게 달라진다는 예기치 못한 사실을 발견하고 본 발명에 이르게 되었다. Therefore, the present inventors are trying to improve the problems of the prior art as described above, when reacting the sulfyl halide organic sulfide when reacting the sulfyl halide with N, N'-dimethyl-3,3'-dithiodipropionamide After diluting in a solvent and reacting dropwise, an unexpected fact was found that the production rate of 5-chloro-2-methyl-4-isothiazolin-3-one salt varies greatly depending on the dilution ratio and the dropping rate of the sulfyl halide. It came to invention.
본 발명은 2-알킬-4-이소티아졸린-3-온을 제조함에 있어서, 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 함유량이 100ppm이하의 극소량만 포함되도록 하는 신규한 제조방법을 제공하는데 그 목적이 있다. The present invention provides a novel method for preparing 2-alkyl-4-isothiazolin-3-one, in which a very small amount of 5-chloro-2-methyl-4-isothiazolin-3-one salt is contained in an amount of 100 ppm or less. It is an object to provide a manufacturing method.
이하, 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.
본 발명은 N,N'-디메틸-3,3'-디티오디프로피온아미드와 설프릴할라이드를 반응시켜 다음 화학식(1)의 2-메틸-4-이소티아졸린-3-온 염을 제조함에 있어서, The present invention is prepared by reacting N, N'-dimethyl-3,3'-dithiodipropionamide with sulfyl halide to prepare 2-methyl-4-isothiazolin-3-one salt of the following formula (1). ,
먼저 N,N'-디메틸-3,3'-디티오디프로피온아미드를 유기할로겐용매에 용해하고, 따로 유기할로겐용매에 설프릴할라이드를 1.5 내지 2.5배의 비율로 희석한 다음, 상기 N,N'-디메틸-3,3'-디티오디프로피온아미드 용액에다 상기 설프릴할라이드 희석액을 20 ~ 30℃의 온도에서 10 ~ 14 시간 동안 적가 반응시키는 것을 특징으로 하는 방법이다.First, N, N'-dimethyl-3,3'-dithiodipropionamide is dissolved in an organic halogen solvent, and the sulfyl halide is separately diluted in an organic halogen solvent at a ratio of 1.5 to 2.5 times, and then the N, N ' The dimethyl-3,3'-dithiodipropionamide solution is added dropwise with the sulfyl halide dilution at a temperature of 20 to 30 ℃ for 10 to 14 hours.
본 발명에서 출발물질로 사용되는 N,N'-디메틸-3,3'-디티오디프로피온아미드는 종래의 방법에 따라서 제조 할 수 있다. 예컨대, 먼저 3,3'-디티오디프로피온산과 티오닐클로라이드를 반응시켜 3,3'-디티오디프로피오닐디클로라이드를 제조하고, 이를 메틸아민과 반응시켜서 N,N'-디메틸-3,3'-디티오디프로피온아미드를 제조 할 수 있다.N, N'-dimethyl-3,3'-dithiodipropionamide used as a starting material in the present invention can be prepared according to a conventional method. For example, 3,3'-dithiodipropionyldichloride is prepared by first reacting 3,3'-dithiodipropionic acid with thionyl chloride, which is reacted with methylamine to give N, N'-dimethyl-3,3 '. Dithiodipropionamide can be prepared.
본 발명의 특징은 상기 N,N'-디메틸-3,3'-디티오디프로피온아미드와 염소화제인 설프릴할라이드를 반응시킬때, 설프릴할라이드를 유기할로겐용매에 희석하여 10 ~ 14시간 동안 서서히 적가하면서 반응시키는 것이다. 이때, 출발물질인 N,N'-디메틸-3,3'-디티오디프로피온아미드를 먼저 유기할로겐용매에 용해시키고, 여기에다 설프릴할라이드 희석액을 적가하되 N,N'-디메틸-3,3'-디티오디프로피온아미드에 대한 설프릴할라이드의 반응 비율이 1 : 2.5 내지 3.5의 몰비가 되도록 하는 것이 적합하다. 만일 상기 반응 비율이 2.5 몰비 이하이면 반응 수율이 저조하게 되고, 3.5 몰비 이상이면 증량에 따른 효과가 나타나지 않는다.A characteristic of the present invention is that when reacting the N, N'-dimethyl-3,3'-dithiodipropionamide and the sulfyl halide, which is a chlorinating agent, the sulfyl halide is diluted in an organic halogen solvent and then gradually cooled for 10 to 14 hours. React as you add. At this time, the starting material N, N'-dimethyl-3,3'-dithiodipropionamide is first dissolved in an organic halogen solvent, and a distillation solution of sulfyl halide is added dropwise thereto to N, N'-dimethyl-3,3'- It is suitable that the reaction ratio of sulfyl halide to dithiodipropionamide is in a molar ratio of 1: 2.5 to 3.5. If the reaction ratio is less than 2.5 molar ratio, the reaction yield is low, and if the reaction ratio is more than 3.5 molar ratio, there is no effect according to the increase.
또한, 유기할로겐용매에 대한 설프릴할라이드의 희석 비율은 유기할로겐용매에 대하여 1.5 내지 2.5배의 비율이 되도록 한다. 만일, 설프릴할라이드의 희석 비율이 1.5배 이하이면 부산물인 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 함량이 크게 증가되고, 반대로 2.5배 이상이면 증량에 따른 효과가 거의 나타나지 않는다.In addition, the dilution ratio of sulfyl halide to the organic halogen solvent is 1.5 to 2.5 times the ratio of the organic halogen solvent. If the dilution ratio of the sulfyl halide is 1.5 times or less, the content of 5-chloro-2-methyl-4-isothiazolin-3-one salt as a by-product is greatly increased. Does not appear
본 발명에 있어서, 유기할로겐용매로는 에틸렌디클로라이드, 메틸렌디클로라이드, 에틸아세테이트 또는 클로로포름 등을 사용할 수 있으나, 에틸렌디클로라이드를 사용하는 것이 가장 좋다. 또한, 설프릴할라이드로는 설프릴클로라이드를 사용하는 것이 가장 좋다.In the present invention, as the organic halogen solvent, ethylene dichloride, methylene dichloride, ethyl acetate or chloroform may be used, but ethylene dichloride is best used. In addition, it is best to use sulfyl chloride as the sulfyl halide.
본 발명의 다른 특징은 상기 적가 반응을 20 ~ 30℃의 온도에서 실시한다는 점이다. 만일, 반응온도가 20℃ 이하로 되면 반응 수율이 떨어지고, 30℃ 이상이 되면 부반응이 나타날 우려가 있다.Another feature of the invention is that the dropping reaction is carried out at a temperature of 20 to 30 ℃. If the reaction temperature is 20 ° C or less, the reaction yield is lowered, and when the reaction temperature is 30 ° C or more, side reactions may occur.
본 발명에 따라 제조된 2-메틸-4-이소티아졸린-3-온 염은 이를 공지의 방법에 따라 알카리염으로 중화하여 염화수소를 제거하므로서, 공업용 방부제나 살균제 등으로 사용되는 2-메틸-4-이소티아졸린-3-온을 제조할 수 있다. The 2-methyl-4-isothiazolin-3-one salt prepared according to the present invention is neutralized with an alkali salt according to a known method to remove hydrogen chloride, and thus 2-methyl-4 is used as an industrial preservative or bactericide. Isothiazolin-3-ones can be prepared.
한편, 설프릴할라이드의 적가 속도 및 희석비율과 5-클로로-2-메틸-4-이소티아졸린-3-온 염( CMIT라 함 )의 생성량에 대한 상관관계를 알아보면 다음과 같다. 다음 표1은 설프릴클로라이드 원액 100 g의 적가 시간을 2.9시간( 적가속도 : 시간당 35 g)에서 20시간( 적가속도 : 시간당 5 g)으로 증가시키면서 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 생성량의 변화를 측정하여 나타낸 것이고, 첨부한 도1은 표 1의 결과를 그래프로 나타낸 것이다. On the other hand, the correlation between the dropping rate and dilution ratio of the sulfyl halide and the amount of 5-chloro-2-methyl-4-isothiazolin-3-one salt (called CMIT) is as follows. Table 1 shows the 5-chloro-2-methyl-4-isothia with increasing the dropping time of 100 g of sulfyl chloride stock solution from 2.9 hours (dropping rate: 35 g per hour) to 20 hours (dropping rate: 5 g per hour). The change in the amount of production of the zolin-3-one salt was measured and shown, and FIG. 1 is a graph showing the results of Table 1. FIG.
상기의 표1과 도1에서 알 수 있는 바와 같이, 설프릴클로라이드를 유기용매에 희석하지 않고 적가시간 만을 늘려서 반응시켰을 때, 10시간까지는 5-클로로-2-알킬-4-이소티아졸린-3-온 염의 함량이 점차 감소하여 550∼850ppm 까지 감소하였으나 14시간 이상에서는 적가시간을 더 연장하더라도 5-클로로-2-알킬-4-이소티아졸린-3-온 염의 생성을 억제시키는 효과는 거의 없는 것으로 나타났다. 또한, 이와같이 설프릴클로라이드를 유기용매에 희석하지 않고 원액 그대로 적가할 경우에는 5-클로로-2-알킬-4-이소티아졸린-3-온 염의 생성량을 320 ppm 이하로 감소시키기는 실질적으로 불가능한 것으로 나타났다.As can be seen from Table 1 and FIG. 1, when the sulfyl chloride was reacted by increasing the dropping time without diluting the organic solvent, 5-chloro-2-alkyl-4-isothiazoline-3 was added for up to 10 hours. -The content of warm salt gradually decreased to 550 ~ 850ppm, but there was little effect of inhibiting the production of 5-chloro-2-alkyl-4-isothiazolin-3-one salt even if the drop time was extended more than 14 hours. Appeared. In addition, it is practically impossible to reduce the amount of 5-chloro-2-alkyl-4-isothiazolin-3-one salt to 320 ppm or less when the sulfyl chloride is added dropwise without dilution with an organic solvent. appear.
한편, 다음 표2는 설프릴클로라이드를 에틸렌디클로라이드에 희석하여 적가하되, 이때 설프릴클로라이드의 희석 비율을 0.5배에서 3배까지 차례로 변화시키면서 각 희석비율에 대한 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 생성량의 변화를 측정하여 나타낸 것이고, 첨부한 도2는 표2의 결과를 그래프로 나타낸 것이다. On the other hand, the following Table 2 is added dropwise by diluting the sulfyl chloride in ethylene dichloride, wherein the dilution ratio of the sulfyl chloride from 0.5 to 3 times in order to change the 5-chloro-2-methyl-4 for each dilution ratio -The change of the production amount of the isothiazolin-3-one salt was measured and shown, and the accompanying FIG. 2 shows the result of Table 2 graphically.
상기 표2 및 도2에서 알 수 있는 바와 같이, 설프릴클로라이드를 에틸렌디클로라이드에 희석하여 적가하는 경우에는 에틸렌디클로라이드에 대한 설프릴클로라이드의 희석비율이 1.5내지 2.5배 일 때 5-클로로-2-알킬-4-이소티아졸린-3-온 염의 생성을 가장 효과적으로 억제시키는 것으로 나타났다.As can be seen in Table 2 and FIG. 2, when the sulfyl chloride is added dropwise to ethylene dichloride and added dropwise, 5-chloro-2 when the dilution ratio of sulfyl chloride to ethylene dichloride is 1.5 to 2.5 times. It has been shown to most effectively inhibit the production of -alkyl-4-isothiazolin-3-one salts.
이하, 본 발명을 실시예에 의거 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to Examples.
실시예 1Example 1
1ℓ 3구 플라스크에 N, N'-디메틸-3, 3'-디티오프로피온아미드 60.7g(0.256 몰)를 에틸렌디클로라이드 250g에 녹인 후, 20∼30℃를 유지하면서 교반한다. 이 용액에다 설프릴클로라이드 100g(0.738 몰)을 에틸렌디클로라이드 250g에 희석한 용액을 10∼12시간 동안 적가한다. 동 온도에서 12시간 동안 반응한 후 5℃로 냉각하여 여과한다. 여과한 결정을 오븐에서 건조하여 2-메틸-4-이소티아졸린-3-온 염 70.2g(90.5 몰%)을 얻는다.60.7 g (0.256 mol) of N, N'-dimethyl-3 and 3'-dithiopropionamide were dissolved in 250 g of ethylene dichloride in a 1 L three-neck flask, followed by stirring while maintaining 20 to 30 ° C. To this solution was added dropwise a solution of 100 g (0.738 mol) of sulfyl chloride in 250 g of ethylene dichloride for 10 to 12 hours. After reacting at the same temperature for 12 hours, the mixture was cooled to 5 ° C. and filtered. The filtered crystals are dried in an oven to give 70.2 g (90.5 mol%) of 2-methyl-4-isothiazolin-3-one salt.
실시예 2Example 2
1ℓ 3구 플라스크에 N, N'-디메틸-3, 3'-디티오프로피온아미드 60.7g(0.256 몰)를 메틸렌클로라이드 250g에 녹인 후 20∼30℃를 유지하면서 교반 한다. 이 용액에다 설프릴클로라이드 100g(0.738 몰)을 메틸렌클로라이드 250g에 희석한 액을 12∼14시간 동안 적가한다. 동 온도에서 12시간 동안 반응한 후 5℃로 냉각하여 여과한다. 여과한 결정을 오븐에서 건조하여 2-메틸-4-이소티아졸린-3-온 염 68.5g(88.4 몰%)을 얻는다.In a 1 L three-necked flask, 60.7 g (0.256 mol) of N, N'-dimethyl-3 and 3'-dithiopropionamide were dissolved in 250 g of methylene chloride, followed by stirring while maintaining 20 to 30 ° C. To this solution was added dropwise a solution of 100 g (0.738 mol) of sulfyl chloride in 250 g of methylene chloride for 12-14 hours. After reacting at the same temperature for 12 hours, the mixture was cooled to 5 ° C. and filtered. The filtered crystals are dried in an oven to give 68.5 g (88.4 mol%) of 2-methyl-4-isothiazolin-3-one salt.
실시예 3Example 3
1ℓ 3구 플라스크에 N, N'-디메틸-3, 3'-디티오프로피온아미드 60.7g(0.256 몰)를 에틸아세테이트 250g에 녹인 후 20∼30℃를 유지하면서 교반 한다. 이 용액에다 설프릴클로라이드 100g(0.738 몰)을 에틸아세테이트 250g에 희석한 액을 10∼12시간 동안 적가한다. 동 온도에서 12시간 동안 반응한 후 5℃로 냉각하여 여과한다. 여과한 결정을 오븐에서 건조하여 2-메틸-4-이소티아졸린-3-온 염 68.9g(88.9 몰%)을 얻는다.In a 1 L three-necked flask, 60.7 g (0.256 mol) of N, N'-dimethyl-3, 3'-dithiopropionamide was dissolved in 250 g of ethyl acetate, followed by stirring while maintaining 20 to 30 ° C. To this solution was added dropwise a solution of 100 g (0.738 mol) of sulfyl chloride in 250 g of ethyl acetate for 10 to 12 hours. After reacting at the same temperature for 12 hours, the mixture was cooled to 5 ° C. and filtered. The filtered crystals are dried in an oven to give 68.9 g (88.9 mol%) of 2-methyl-4-isothiazolin-3-one salt.
실시예 4Example 4
1ℓ 3구 플라스크에 N, N'-디메틸-3, 3'-디티오프로피온아미드 60.7g(0.256 몰)를 클로로포름 250g에 녹인 후 20∼30℃를 유지하면서 교반 한다. 이 용액에다설프릴클로라이드 100g(0.738 몰)을 클로로포름 250g에 희석한 용액을 13∼14시간 동안 적가한다. 동 온도에서 12시간 동안 반응한 후 5℃로 냉각하여 여과한다. 여과한 결정을 오븐에서 건조하여 2-메틸-4-이소티아졸린-3-온 염 69.4g(89.5 몰%)을 얻는다.In a 1 L three-necked flask, 60.7 g (0.256 mol) of N, N'-dimethyl-3 and 3'-dithiopropionamide was dissolved in 250 g of chloroform, followed by stirring while maintaining 20 to 30 ° C. To this solution was added dropwise a solution of 100 g (0.738 mol) of sulfaryl chloride in 250 g of chloroform for 13 to 14 hours. After reacting at the same temperature for 12 hours, the mixture was cooled to 5 ° C. and filtered. The filtered crystals are dried in an oven to give 69.4 g (89.5 mol%) of 2-methyl-4-isothiazolin-3-one salt.
본 발명에 따르면 2-알킬-4-이소티아졸린-3-온 염을 제조함에 있어서, 5-클로로-2-메틸-4-이소티아졸린-3-온 염의 함유량이 100ppm이하로 포함되어 있어서 산업적으로 이용 가능한 2-알킬-4-이소티아졸린-3-온 염을 제조할 수 있다.In the preparation of the 2-alkyl-4-isothiazolin-3-one salt according to the present invention, the content of 5-chloro-2-methyl-4-isothiazolin-3-one salt is contained in an amount of 100 ppm or less. 2-alkyl-4-isothiazolin-3-one salts can be prepared that can be used.
도 1은 설프릴클로라이드 원액의 적가시간과 5-클로로-2-메틸-4-이소티아졸린-3-온 염(CMIT)의 생성량과의 상관관계를 나타낸 그래프이고,1 is a graph showing the correlation between the dropping time of a sulfyl chloride stock solution and the amount of 5-chloro-2-methyl-4-isothiazolin-3-one salt (CMIT);
도 2는 에틸렌디클로라이드에 대한 설프릴클로라이드의 희석비율과 5-클로로-2-메틸-4-이소티아졸린-3-온 염( CMIT )의 생성량과의 관계를 나타낸 그래프이다.2 is a graph showing the relationship between the dilution ratio of sulfyl chloride to ethylene dichloride and the amount of 5-chloro-2-methyl-4-isothiazolin-3-one salt (CMIT).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0068236A KR100493934B1 (en) | 2002-11-05 | 2002-11-05 | The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0068236A KR100493934B1 (en) | 2002-11-05 | 2002-11-05 | The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040039974A KR20040039974A (en) | 2004-05-12 |
KR100493934B1 true KR100493934B1 (en) | 2005-06-10 |
Family
ID=37337482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0068236A KR100493934B1 (en) | 2002-11-05 | 2002-11-05 | The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100493934B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102786491A (en) * | 2011-05-19 | 2012-11-21 | 大连百傲化学有限公司 | Preparation method of 2-methyl-4-isothiazolin-3-one |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR200453526Y1 (en) * | 2008-12-22 | 2011-05-11 | 이명진 | The shake prevention device for roll screen |
KR101012334B1 (en) * | 2009-02-17 | 2011-02-09 | (주)티엔씨애드컴 | Apparatus for enabling advertisement on buoy and method thereof |
CN113979965B (en) * | 2021-10-27 | 2023-07-28 | 陕西中杰科仪化学科技有限公司 | Continuous production method of 4, 5-dichloro-2-octyl-4-isothiazolin-3-ketone |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3849430A (en) * | 1967-03-09 | 1974-11-19 | Rohm & Haas | Process for the preparation of 3-isothiazolones and 3-hydroxyisothiazoles |
KR940000239A (en) * | 1992-06-30 | 1994-01-03 | 박원근 | Continuous welding device of polymer sheet |
KR0180562B1 (en) * | 1992-12-22 | 1999-03-20 | 이승동 | Preparation process of 2-methyl-4-isothiazoline-3-on salt |
KR100212963B1 (en) * | 1995-12-21 | 1999-08-02 | 조민호 | A stabilized isothiazolone composition and process for preparing isothiazolones |
KR20040022598A (en) * | 2002-09-09 | 2004-03-16 | 주식회사 한서켐 | The manufaturing process for methyl-4-isothiazoline-3-one and the salt thereof |
-
2002
- 2002-11-05 KR KR10-2002-0068236A patent/KR100493934B1/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3849430A (en) * | 1967-03-09 | 1974-11-19 | Rohm & Haas | Process for the preparation of 3-isothiazolones and 3-hydroxyisothiazoles |
KR940000239A (en) * | 1992-06-30 | 1994-01-03 | 박원근 | Continuous welding device of polymer sheet |
KR0180562B1 (en) * | 1992-12-22 | 1999-03-20 | 이승동 | Preparation process of 2-methyl-4-isothiazoline-3-on salt |
KR100212963B1 (en) * | 1995-12-21 | 1999-08-02 | 조민호 | A stabilized isothiazolone composition and process for preparing isothiazolones |
KR20040022598A (en) * | 2002-09-09 | 2004-03-16 | 주식회사 한서켐 | The manufaturing process for methyl-4-isothiazoline-3-one and the salt thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102786491A (en) * | 2011-05-19 | 2012-11-21 | 大连百傲化学有限公司 | Preparation method of 2-methyl-4-isothiazolin-3-one |
Also Published As
Publication number | Publication date |
---|---|
KR20040039974A (en) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07119164B2 (en) | Process for producing water-soluble 3-isothiazolone composition for biocide | |
KR100493934B1 (en) | The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one | |
US5453507A (en) | Process for preparing 4-isothiazolin-3-one | |
CN111689852B (en) | Preparation method of 2,3,5,6-tetrachlorobenzoyl chloride | |
EP2190828B1 (en) | Process for preparing cyanimino-1,3-thiazolidines | |
US20210032211A1 (en) | Processes for the synthesis of sulfentrazone | |
KR20010062688A (en) | Method for Producing 2-Alkyl-4-Isothiazoline-3-One | |
KR100780564B1 (en) | Method for producing 2-chloro-5-chloromethyl-1,3-thiazole | |
KR101276667B1 (en) | Process for preparing 3,4-dichloroisothiazolecarboxylic acid | |
US9334241B2 (en) | Process for the preparation of N-substituted pyrazole compounds | |
EP3350172A1 (en) | Procedure for the preparation of 2-cyanoimino-1,3-thiazolidine | |
JPS58124764A (en) | Production of optically active thiol | |
KR101004368B1 (en) | Preparation method of n,n'-substituted-3,3'-dithiodipropioneamide and preparation method of substituted 3-isothiazolone using the same | |
KR100493933B1 (en) | The manufaturing process for methyl-4-isothiazoline-3-one and the salt thereof | |
CS214692B2 (en) | Method of making the hydrochloride of 6,7-dimethoxy-4-amino-2-+l4-+l2-furoyl+p-1-piperazinyl+pchnazoline | |
JP6477187B2 (en) | Process for producing 2-amino-6-methylnicotinic acid ester | |
EP1660480A1 (en) | A process for the preparation of cilostazol and of the intermediates thereof | |
CN110183428B (en) | Furan thiocarbamate compound containing 1,2,3, 4-tetrazole and preparation method and application thereof | |
JP4271924B2 (en) | Method for producing 4-mercaptophenols | |
KR940000239B1 (en) | Process for preparing 2-methyl-4-isothiazoline-3-one | |
KR100285281B1 (en) | Process for producing 3-isothiazolone salt mixture | |
KR100477763B1 (en) | The Novel preparation of Intermediate of Cefatrizine Propylene gylcol | |
KR100537385B1 (en) | Process for preparing sodium thiofuroate | |
JP4296268B2 (en) | Novel N-sulfenyl substituted heterocyclic compound and method for producing the same | |
JPH0439464B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120525 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130731 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180611 Year of fee payment: 14 |
|
LAPS | Lapse due to unpaid annual fee |